Why Screen for Mild Cognitive Impairment (MCI)?

3 min read 

Globally, 3 in 20 people are affected by MCI and the risk of developing MCI increases with age. Brain health issues can develop at any stage of life, often going unnoticed or until it’s too late. Therefore, early screening of cognition is crucial to maintain cognitive function as we age.

Neurowyzr’s Digital Brain Function Screen (DBFS) offers an easy-to-use and accessible way to flag out any changes or decline in cognition. This tool assesses key areas of cognition, including attention, immediate memory, working memory, and executive function. Regular screening with DBFS can help to monitor for cognition, providing valuable insights into specific cognitive domain impairments.

Detecting cognitive decline early allows for effective intervention through lifestyle modifications, such as adjusting nutrition, exercise, sleep habits and better management of vascular conditions. Early detection of MCI empowers individuals to take proactive steps to safeguard their cognitive abilities to increase quality of life.

Early detection of MCI empowers individuals to take proactive steps to safeguard their cognitive abilities to increase quality of life

References: 

Bai, W., Chen, P., Cai, H., Zhang, Q., Su, Z., Cheung, T., … & Xiang, Y. T. (2022). Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age and ageing51(8), afac173.

Related Articles

Related

What is Mild Cognitive Impairment (MCI)?

3 min read Mild cognitive impairment (MCI) is regarded as the stage between normal cognition and dementia. MCI is defined as the presentation of objective cognitive impairment on neuropsychological testing with minimal impairment to daily functioning.There are...

read more

Get new articles directly to your email